Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
BEIJING PHABUILDER BIOTECHNOLOGY CO., LTD. currently has 1 pending office action within the Chemistry & Materials technology area. This single action is assigned to 1 distinct examiner, concentrating the company's immediate prosecution efforts under a single point of review. The data shows 1 distinct art unit associated with these filings, which indicates a specific technical classification for the pending matter. This centralized structure allows for a focused legal strategy within the Chemistry & Materials sector.
ILLING, CAITLIN NORINE serves as the busiest examiner for the portfolio, holding 1 busiest examiner pending office action. Because there is only 1 pending office action in total, this examiner manages the entirety of the company's active workload. The alignment between the 1 distinct examiner and the 1 busiest examiner pending action highlights a prosecution environment where all current feedback originates from ILLING, CAITLIN NORINE. The presence of 1 distinct art unit further confirms that the company's current activity is confined to a single technical review group.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ILLING, CAITLIN NORINE | 1 | 47.9% | +38.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18294331 | MODIFICATION METHOD OF POLYHYDROXYALKANOATE | ILLING, CAITLIN NORINE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18294331 | MODIFICATION METHOD OF POLYHYDROXYALKANOATE | ILLING, CAITLIN NORINE | — |
| Art Unit | Apps |
|---|---|
| 1762 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18294331 | MODIFICATION METHOD OF POLYHYDROXYALKANOATE | ILLING, CAITLIN NORINE | 1762 | §102§103§112 | Non-Final OA | — | Pending | Feb 01, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBEIJING PHABUILDER BIOTECHNOLOGY CO., LTD. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Caitlin Norine Illing has the most, with 1 of BEIJING PHABUILDER BIOTECHNOLOGY CO., LTD.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
